Julia G. Butchko has sold IMVT and made no open-market buys since Jan 2022

Chief Development Officer at Immunovant, Inc.

SEC CIK 0001796290 · Filings on SEC.gov ↗

$0Bought

$2.7MSold

NoneLast buy

Every filing

15 filings since Jan 2022, newest first

IMVTSell

Immunovant, Inc.

Chief Development Officer

$96K−1.0%Aug 23

IMVTSell

Immunovant, Inc.

Chief Development Officer

$85K−1.0%Jul 19

IMVTSell

Immunovant, Inc.

Chief Development Officer

$43KJul 10

IMVTSell

Immunovant, Inc.

Chief Development Officer

$96K−1.0%May 24

IMVTSell

Immunovant, Inc.

Chief Development Officer

$294K−2.0%Apr 19

IMVTSell

Immunovant, Inc.

Chief Development Officer

$33KApr 10

IMVTSell

Immunovant, Inc.

Chief Development Officer

$78K−1.0%Feb 23

IMVTSell

Immunovant, Inc.

Chief Development Officer

$50KJan 9

IMVTSell

Immunovant, Inc.

Chief Development Officer

$107K−1.0%Nov 24

IMVTSell

Immunovant, Inc.

Chief Development Officer

$63KOct 6

IMVTSell

Immunovant, Inc.

Chief Development Officer

$250K−3.0%Aug 25

IMVTSell

Immunovant, Inc.

Chief Development Officer

$29KJul 13

IMVTSell

Immunovant, Inc.

Chief Dev., Tech. Officer

$1.0M−15.0%Jan 13

IMVTSell

Immunovant, Inc.

Chief Dev., Tech. Officer

$38K−2.0%Apr 14

IMVTSell

Immunovant, Inc.

Chief Dev., Tech. Officer

$401K−16.0%Jan 11

Filings come from SEC EDGAR. Not investment advice.